Allergan has appointed company veteran Douglas Ingram as the company’s first president.
Ingram, who has spent 17 years at Allegan, will lead the company’s global commercial operations, holding responsibility for a product portfolio that includes Botox as well as several ophthalmology treatments.
He most recently spent three years as executive VP and president, Europe, Africa and Middle East (EAME).
Other roles during his extensive period at Allergan include chief administrative officer and chief ethics officer.
He rose to these roles having joined the company as senior attorney and chief litigation officer in 1996.
Before joining Allergan, Ingram was an attorney with Gibson, Dunn & Crutcher from 1988, practicing in the area of complex commercial litigation.
“Doug has built an impressive record of accomplishment and is widely regarded throughout our organisation as a leader who is committed to the highest standards of excellence in all areas,” said David Pyott, chairman of the board and CEO, Allergan.